Sun Pharmaceutical Industries Ltd 2021 SR
The report marks Sun Pharma's first sustainability disclosure, covering the fiscal year 2020-2021. Key highlights include achieving approximately 38% renewable energy usage and ensuring 86% of manufacturing facilities are Zero Liquid Discharge. The company pledged to reduce greenhouse gas emissions as a signatory to the India CEO Forum on Climate Change. Socially, the company invested ₹575 million in CSR, focusing on healthcare, education, and COVID-19 relief. It also emphasizes product stewardship through a global pharmacovigilance system established in 2005.
Company: Sun Pharmaceutical Industries Ltd
Sector: Manufacturing
Country: India
Year: 2021
Type: SR
Pages: 43
Back to company
Sun Pharmaceutical Industries Ltd
Sustainability Report
The report marks Sun Pharma's first sustainability disclosure, covering the fiscal year 2020-2021. Key highlights include achieving approximately 38% renewable energy usage and ensuring 86% of manufacturing facilities are Zero Liquid Discharge. The company pledged to reduce greenhouse gas emissions as a signatory to the India CEO Forum on Climate Change. Socially, the company invested ₹575 million in CSR, focusing on healthcare, education, and COVID-19 relief. It also emphasizes product stewardship through a global pharmacovigilance system established in 2005.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Apr 1, 2020 - Mar 31, 2021
Fiscal Year
2021
Published
Aug 16, 2021
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees